Publications for Preclinical Pharmacology Core

2019 PUBLICATIONS (core staff in bold)

  1. Zhang LS, Kang X, Lu J, Zhang Y, Wu X, Wu G, Zheng J, Tuladhar R, Shi H, Wang Q, Morlock L, Yao H, Huang LJ, Maire P, Kim J, Williams N, Xu J, Chen C, Zhang CC, Lum L. Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9. EBioMedicine. 2019 39:145-158. PMCID: PMC6354558.
  2. Motea EA, Huang X, Singh N, Kilgore JA, Williams NS, Xie XJ, Gerber DE, Beg M, Bey EA, Boothman DA. NQO1-dependent, tumor-selective radiosensitization of non-small cell lung cancers. Clin Cancer Res. 2019 Jan 7. pii: clincanres.2560.2018. PubMed PMID: 30617135.
  3. Shi Y, Lim SK, Liang Q, Iyer SV, Wang HY, Wang Z, Xie X, Sun D, Chen YJ, Tabar V, Gutin P, Williams N, De Brabander JK, Parada LF. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature. 2019 Mar;567 (7748):341-346. PubMed PMID: 30842654.